This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

DuPont Pushes Up Forecast

DuPont (DD - Get Report) raised its full-year forecast and said it was upbeat on 2008, but it offered somewhat cautious commentary on the health of the U.S.

This year, DuPont now expects to earn $3.15 to $3.20 a share, excluding a charge, up from its prior projection of around $3.15. For the fourth quarter, the chemicals company expects that strong sales growth outside the U.S. will continue to exceed the effect of lower demand from the domestic housing and auto markets.

However, net income growth in the last quarter of the year will probably be tempered by a much higher base tax rate compared with the prior year.

DuPont said its 2008 outlook is positive, and it expects solid revenue expansion in emerging markets and significant earnings growth in its agriculture and nutrition segment. But the optimistic view is being moderated by potentially lower demand from U.S. housing and automotive markets and the uncertainty of ingredient costs, DuPont said.

The company's goal is for next year's earnings to grow about 5% to 10% from its anticipated 2007 results, implying a profit range of around $3.31 to $3.52. Analysts are looking for $3.15 this year and $3.41 next year.

DuPont's outlook came as the company reported third-quarter earnings of 56 cents a share, up from 52 cents a year ago. Stripping out items, earnings would have been 59 cents, 7 cents better than analysts predicted.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs